SCHEMBL13757919

SCHEMBL13757919

CCOc1cc(OCCN2C(=O)[C@@H](NC(=O)OC(C)(C)C)CCCCCCC[C@@H]3C[C@@]3(C(=O)NS(=O)(=O)OC3(C)CC3)NC(=O)[C@@H]2C)c2cccc(Cl)c2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8142742 0.86 CYP3A4 (0.40) —
SCHEMBL8140808 0.79 CYP3A4 (0.39) —
SCHEMBL13757916 0.74 ADRB3 (0.40) —
SCHEMBL3373349 0.74 ADRB3 (0.40) —
SCHEMBL8148186 0.70 CYP3A4 (0.37) —
SCHEMBL3809700 0.68 ADRB3 (0.49) —
SCHEMBL13757917 0.68 ADRB3 (0.49) —
SCHEMBL3809694 0.68 ADRB3 (0.49) —
SCHEMBL8141694 0.67 CYP3A4 (0.47) —
SCHEMBL8143213 0.65 CYP3A4 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051626-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2014-02-20 — — US disclosed
US-8513186-B2 Antiviral compounds GILEAD SCIENCES, INC. (US) 2013-08-20 — — US disclosed
US-8513186-B2 Antiviral compounds GILEAD SCIENCES, INC. (US) 2013-08-20 — — US disclosed
US-20090186869-A1 Antiviral compounds GILEAD SCIENCES, INC. (US) 2009-07-23 — — US disclosed
US-20090186869-A1 Antiviral compounds GILEAD SCIENCES, INC. (US) 2009-07-23 — — US disclosed
Send feedback